PDCD1 and neoplasm: Zhang et al. (2017) produced an anti-PD-L1 Nb (KN035) and demonstrated that KN035-Fc blocked the PD-L1– PD-1 interaction, induced IFN-γ production and inhibited tumor growth (Table 3) [99].